Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-09 Purchase |
2023-06-13 4:41 pm |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
511 | $3.42 | $1,748 | 1,262 (Direct) |
View |
| 2021-12-10 Purchase |
2021-12-14 5:17 pm |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Accounting Officer |
955 | $1.57 | $1,499 | 9,004 (Direct) |
View |
| 2020-12-10 Purchase |
2020-12-14 4:12 pm |
Cerecor Inc. | CERC | Sullivan Christopher Ryan Interim CFO |
5,095 | $2.278 | $11,606 | 8,049 (Direct) |
View |
| 2020-06-10 Purchase |
2020-06-11 9:08 pm |
Cerecor Inc. | CERC | Sullivan Christopher Ryan Interim CFO |
2,954 | $2.278 | $6,729 | 2,954 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-28 Exercise |
2025-04-01 4:11 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
24,200 | $0 | 65,321 (Direct) |
View |
| 2025-03-28 Tax Withholding |
2025-04-01 4:11 pm |
N/A N/A |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
7,285 | $8.46 | 65,321 (Direct) |
View |
| 2025-01-28 Option Award |
2025-01-30 5:43 pm |
N/A 2035-01-28 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
163,000 | $0 | 163,000 (Direct) |
View |
| 2024-08-13 Option Award |
2024-08-14 4:11 pm |
N/A 2034-08-13 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
259,300 | $0 | 259,306 (Direct) |
View |
| 2023-05-15 Option Award |
2023-05-17 07:44 am |
2024-05-15 2033-05-15 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:19 pm |
N/A 2033-02-13 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-10-05 Option Award |
2022-10-07 4:01 pm |
2023-10-05 2032-10-05 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-10 5:50 pm |
N/A 2032-03-08 |
Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-28 4:08 pm |
N/A 2031-01-26 |
Cerecor Inc. | CERC | Sullivan Christopher Ryan Interim CFO |
110,000 | $0 | 110,000 (Direct) |
View |